The Postoperative Lymphocyte to Monocyte Ratio Change Predicts Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Resection

Table 1

Demographic and clinical data of 674 ESCC patients according to LMR change.

Characteristics	(%)	LMRc		value
		≤1.59 (%)	>1.59 () (%)
Sex
Male	576 (85.5)	307 (91.1)	269 (79.8)	<0.001
Female	98 (14.5)	30 (8.9)	68 (20.2)
Age
≤60 years	310 (46.0)	146 (43.3)	164 (48.7)	0.164
>60 years	364 (54.0)	191 (56.7)	173 (51.3)
Pathology grade
Well	49 (7.4)	23 (7.0)	26 (7.8)	0.304
Middle	446 (67.5)	231 (70.0)	215 (65.0)
Poorly	164 (24.8)	76 (23.0)	88 (26.6)
Undifferentiated	2 (0.3)	0 (0)	2 (0.6)
Depth of tumor
T1a–1b	64 (9.5)	29 (8.6)	35 (10.4)	0.670
T2	129 (19.1)	63 (18.7)	66 (19.6)
T3	481 (71.4)	245 (72.7)	236 (70.0)
Lymph node metastasis
N0	293 (43.5)	150 (44.5)	143 (42.4)	0.142
N1	212 (31.5)	101 (30.0)	111 (32.9)
N2	117 (17.4)	53 (15.7)	64 (19.0)
N3	52 (7.7)	33 (9.8)	19 (5.6)
Pathological stage
1a–1b	115 (17.1)	56 (16.6)	59 (17.5)	0.949
2a–2b	226 (33.5)	113 (33.5)	113 (33.5)
3a–3c	333 (49.4)	168 (49.9)	165 (49.0)
Vessel invasive
Yes	206 (30.6)	101 (30.0)	105 (31.2)	0.738
No	468 (69.4)	236 (70.0)	232 (68.8)
Nerve infiltration
Yes	251 (37.2)	125 (37.1)	126 (37.4)	0.936
No	423 (62.8)	212 (62.9)	211 (62.6)
Treatment regimen
S	457 (67.8)	224 (66.5)	233 (69.1)	0.757
S+postoperative C	155 (23.0)	81 (24.0)	74 (22.0)
S+postoperative CRT	62 (9.2)	32 (9.5)	30 (8.9)
Hospital time
≤14 days	560 (83.1)	265 (78.6)	295 (87.5)	0.002
>14 days	114 (16.9)	72 (21.4)	42 (12.5)
NLRc
Median	-3.02 (-4.64–-1.69)	-2.26 (-3.93–-0.95)	-3.78 (-5.39–-2.49)	<0.001
LMRc
Median	1.59 (0.71-2.69)	0.71 (0.05-1.19)	2.68 (2.02-3.54)	<0.001
PLRc
Median	-104.89 (-162.16–-54.85)	-100.65 (-159.19–-38.38)	-108.64 (-163.21–-72.47)	0.003